Skip to Content
Event BSC congress 2026 starts on 29 Jan 2026, 09:00:00 (Europe/Brussels)
S30 - Council on Cardio-oncology - New horizons in cardio-oncology: a paradigm shift in risk, intervention and recovery
Location: Room Foyer - 30/01/2026, 15:15 - 30/01/2026, 16:30 (Europe/Brussels) (1 hour 15 minutes)
Moderators
Lucas Van Aelst - UZ Leuven
Marie Moonen - ULiège

13:55 - 14:20,  Life after treatment: optimizing cardiovascular health in cancer survivors

Evandro de Azambuja, MD, PhD, is the Head of the Medical Support Team (Academic Promoting Team) located at the Institut Jules Bordet, HUB, Université Libre de Bruxelles in Brussels, Belgium


Dr. de Azambuja earned his first PhD from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, in May 2007 and his second PhD from the Université Libre de Bruxelles (U.L.B) in December 2015.


Dr. de Azambuja is a member of different societies including ESMO, ASCO and BSMO. He also has been chairing different ESMO activities such as Fellowship Committee (2018-2022), ESMO Leaders Generation Program (2018-2022). He is the current ESMO membership director 2023-2025 and BSMO (Belgian Society for Medical Oncology) President 2023-2026


He has (co)-authored about 370 peer-reviewed articles and 15 book chapters. He has been a member of Education and Scientific Committees of the ESMO, ESMO Breast, EBCC and ECCO meetings and invited international speaker in different conferences and countries.



14:20 - 14:45,  To intervene or not to intervene: percutaneous options for cancer patients

Liesbeth Rosseel is an interventional cardiologist at the newly merged AZORG Hospital in Aalst, Belgium. She trained in coronary interventions at ZNA Middelheim (Belgium) and structural heart interventions at Rigshospitalet (Copenhagen, Denmark). After serving as a Consultant Cardiologist at Galway University Hospital (Ireland), she returned to Belgium in 2021. She completed her PhD in 2024 on “Lean TAVI” and specializes in structural interventions, including LAAC, PFO/ASD closure, and emerging percutaneous valve therapies.



14:45 - 15:10,  Reverse cardio-oncology: the heart as a risk factor

Wouter C. Meijers MD PhD FESC FHFA

Cardiologist, (Advanced) Heart Failure & Cardio-Oncology